BioMimetic Therapeutics has filed for an IPO designed to raise up to $50 million. The Franklin, TN-based drug device company makes products for musculoskeletal diseases. The FDA handed the company its first approval last year for a product that treats periodontal bone ailments.
- read this release for more
PLUS: Shares of Acorda Therapeutics jumped to $6.40 this morning after debuting at $6. Acorda had initially forecast a share price of $11 to $13. Report